scholarly journals Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination

Oncotarget ◽  
2017 ◽  
Vol 8 (52) ◽  
pp. 89887-89902 ◽  
Author(s):  
Erika Nakatsuka ◽  
Kenjiro Sawada ◽  
Koji Nakamura ◽  
Akihito Yoshimura ◽  
Yasuto Kinose ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Prognostic Factor ◽  
Plasminogen Activator ◽  
Peritoneal Dissemination ◽  
Plasminogen Activator Inhibitor ◽  
Independent Prognostic Factor ◽  
Plasminogen Activator Inhibitor 1 ◽  
Activator Inhibitor

scholarly journals Validating plasminogen activator inhibitor‐1 as a poor prognostic factor in sepsis

2020 ◽  
Vol 7 (1) ◽  
Author(s):  
Kota Hoshino ◽  
Maiko Nakashio ◽  
Junichi Maruyama ◽  
Yuhei Irie ◽  
Yasumasa Kawano ◽  
...  
Keyword(s):  
Prognostic Factor ◽  
Plasminogen Activator ◽  
Plasminogen Activator Inhibitor ◽  
Plasminogen Activator Inhibitor 1 ◽  
Poor Prognostic Factor ◽  
Activator Inhibitor

scholarly journals Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer

2015 ◽  
Vol 16 (2) ◽  
pp. 253-260 ◽  
Author(s):  
Satsuki Mashiko ◽  
Kazuyuki Kitatani ◽  
Masafumi Toyoshima ◽  
Atsuhiko Ichimura ◽  
Takashi Dan ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Plasminogen Activator ◽  
Therapeutic Strategy ◽  
Plasminogen Activator Inhibitor ◽  
Plasminogen Activator Inhibitor 1 ◽  
Activator Inhibitor
Sign in / Sign up

Export Citation Format

Share Document